Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 10, Pages 5375
Publisher
MDPI AG
Online
2021-05-20
DOI
10.3390/ijms22105375
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liver
- (2021) Agostino Di Ciaula et al. European Journal of Internal Medicine
- Tropifexor, a highly potent FXR agonist, produces robust and dose-dependent reductions in hepatic fat and serum alanine aminotransferase in patients with fibrotic NASH after 12 weeks of therapy: FLIGHT-FXR Part C interim results
- (2020) K.J. Lucas et al. DIGESTIVE AND LIVER DISEASE
- Towards genetic prediction of non-alcoholic fatty liver disease trajectories: PNPLA3 and beyond
- (2020) Marcin Krawczyk et al. GASTROENTEROLOGY
- Epidemiological feature of NAFLD from 1999 to 2018 in China
- (2020) Jianghua Zhou et al. HEPATOLOGY
- Increased Colonic Permeability and Lifestyles as Contributing Factors to Obesity and Liver Steatosis
- (2020) Domenica Maria Di Palo et al. Nutrients
- Corilagin Alleviates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced C57BL/6 Mice by Ameliorating Oxidative Stress and Restoring Autophagic Flux
- (2020) Rong Zhang et al. Frontiers in Pharmacology
- Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis
- (2020) Björn Carlsson et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Intrahepatic Fat and Postprandial Glycemia Increase After Consumption of a Diet Enriched in Saturated Fat Compared With Free Sugars
- (2020) Siôn A. Parry et al. DIABETES CARE
- Mitochondrial superoxide/hydrogen peroxide: An emerging therapeutic target for metabolic diseases
- (2020) Jialong Yan et al. FREE RADICAL BIOLOGY AND MEDICINE
- Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
- (2020) Ze Chen et al. FREE RADICAL BIOLOGY AND MEDICINE
- Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
- (2020) Jean-François Dufour et al. GUT
- Nonalcoholic Steatohepatitis
- (2020) Adam C. Sheka et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Endogenous ethanol produced by intestinal bacteria induces mitochondrial dysfunction in nonalcoholic fatty liver disease
- (2020) Xiao Chen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease
- (2020) Jin Wang et al. Lipids in Health and Disease
- A novel non‐bile acid FXR agonist EDP‐305 potently suppresses liver injury and fibrosis without worsening of ductular reaction
- (2020) Ping An et al. LIVER INTERNATIONAL
- A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease
- (2020) Connor A. Emdin et al. PLoS Genetics
- Mitochondrial Dysfunction is a Key Pathway that Links Saturated Fat Intake to the Development and Progression of NAFLD
- (2020) Ruth C. R. Meex et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Acetyl-CoA Carboxylase Inhibition as a Therapeutic Tool in the Battle Against NASH
- (2020) Joeri Lambrecht et al. Cellular and Molecular Gastroenterology and Hepatology
- Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk
- (2020) Agostino Di Ciaula et al. Journal of Clinical Medicine
- Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome
- (2020) Piero Portincasa et al. Nutrients
- The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis
- (2019) Jingjing Cai et al. HEPATOLOGY
- Ursodeoxycholic Acid Regulates Hepatic Energy Homeostasis and White Adipose Tissue Macrophages Polarization in Leptin-Deficiency Obese Mice
- (2019) Yu-Sheng Chen et al. Cells
- Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity
- (2019) Guangrong Dai et al. MEDICINE
- Innate immune regulatory networks in hepatic lipid metabolism
- (2019) Lan Bai et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- F‐box/WD Repeat‐Containing Protein 5 Mediates the Ubiquitination of Apoptosis Signal‐Regulating Kinase 1 and Exacerbates Nonalcoholic Steatohepatitis in Mice
- (2019) Lan Bai et al. HEPATOLOGY
- The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients
- (2019) Aino Latva-Rasku et al. DIABETES CARE
- Daily aspirin use associated with reduced risk for fibrosis progression in patients with nonalcoholic fatty liver disease
- (2019) Tracey G. Simon et al. Clinical Gastroenterology and Hepatology
- Novel MRI assessment of treatment response in HIV ‐associated NAFLD : a randomized trial of an SCD 1 inhibitor ( ARRIVE Trial)
- (2019) Veeral H. Ajmera et al. HEPATOLOGY
- PS-110-Ketohexokinase inhibitor PF-06835919 administered for 6 weeks reduces whole liver fat as measured by magnetic resonance imaging-proton density fat fraction in subjects with non-alcoholic fatty liver disease
- (2019) Roberto Calle et al. JOURNAL OF HEPATOLOGY
- Structure of ATP citrate lyase and the origin of citrate synthase in the Krebs cycle
- (2019) Koen H. G. Verschueren et al. NATURE
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Mitochondria‐Mediated Pathogenesis and Therapeutics for Non‐Alcoholic Fatty Liver Disease
- (2019) Zheng Li et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Non-alcoholic fatty liver disease in non-obese individuals: Prevalence, pathogenesis and treatment
- (2019) Emilio Molina-Molina et al. Clinics and Research in Hepatology and Gastroenterology
- Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial
- (2019) Stefan Traussnigg et al. Lancet Gastroenterology & Hepatology
- REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis
- (2019) Vlad Ratziu et al. Contemporary Clinical Trials
- CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients
- (2019) Paul J. Pockros et al. LIVER INTERNATIONAL
- Mitotherapy as a novel therapeutic strategy for mitochondrial diseases
- (2019) Ailing Fu Current Molecular Pharmacology
- Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study
- (2019) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy
- (2019) Xinyang Yu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
- (2019) Naga Chalasani et al. GASTROENTEROLOGY
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease
- (2019) Ze Chen et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Physical exercise and liver “fitness”: Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease
- (2019) Jelena Stevanović et al. Molecular Metabolism
- Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis
- (2018) Srilaxmi Kalavalapalli et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
- (2018) Juan Pablo Arab et al. Annual Review of Pathology-Mechanisms of Disease
- Dihydromyricetin Ameliorates Nonalcoholic Fatty Liver Disease by Improving Mitochondrial Respiratory Capacity and Redox Homeostasis Through Modulation of SIRT3 Signaling
- (2018) Xianglong Zeng et al. ANTIOXIDANTS & REDOX SIGNALING
- 20-Week follow-up of hepatic steatosis installation and liver mitochondrial structure and activity and their interrelation in rats fed a high-fat–high-fructose diet
- (2018) Gilles Fouret et al. BRITISH JOURNAL OF NUTRITION
- Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
- (2018) Varman T. Samuel et al. Cell Metabolism
- Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial
- (2018) Sasan Amanat et al. CLINICAL NUTRITION
- The Natural History of Nonalcoholic Fatty Liver Disease—An Evolving View
- (2018) Christina C. Lindenmeyer et al. Clinics in Liver Disease
- The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease
- (2018) Puneet Puri et al. Clinics in Liver Disease
- Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
- (2018) Mohammad Shafi Kuchay et al. DIABETES CARE
- Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
- (2018) Jan W. Eriksson et al. DIABETOLOGIA
- The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure
- (2018) Merlin C. Thomas et al. DIABETOLOGIA
- Exercising the hepatobiliary-gut axis. The impact of physical activity performance
- (2018) Emilio Molina-Molina et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Obesity phenotypes and their paradoxical association with cardiovascular diseases
- (2018) Alessandra Vecchié et al. European Journal of Internal Medicine
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- (2018) Scott L. Friedman et al. HEPATOLOGY
- Cenicriviroc treatment for adults with non-alcoholic steatohepatitis: Year 2 analysis of the Phase 2b CENTAUR study
- (2018) V. Ratziu et al. JOURNAL OF HEPATOLOGY
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2018) Stephen A Harrison et al. LANCET
- Mitochondrial adaptation in steatotic mice
- (2018) Claudia Einer et al. MITOCHONDRION
- The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis
- (2018) Yan-Xiao Ji et al. NATURE MEDICINE
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
- (2018) Noura S. Abul-Husn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemoproteomics reveals baicalin activates hepatic CPT1 to ameliorate diet-induced obesity and hepatic steatosis
- (2018) Jianye Dai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases
- (2018) Jingjing Cai et al. Annual Review of Pathology-Mechanisms of Disease
- Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOME® trial
- (2018) Naveed Sattar et al. DIABETOLOGIA
- Mitochondrial dysfunction-related lipid changes occur in non-alcoholic fatty liver disease progression
- (2018) Kang-Yu Peng et al. JOURNAL OF LIPID RESEARCH
- Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-Analysis
- (2018) Yung Lee et al. Clinical Gastroenterology and Hepatology
- Present and emerging pharmacotherapies for non-alcoholic steatohepatitis in adults
- (2018) Yuji Ogawa et al. EXPERT OPINION ON PHARMACOTHERAPY
- GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Rohit Loomba et al. GASTROENTEROLOGY
- Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
- (2018) Arun Sanyal et al. LANCET
- Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease
- (2018) Ignazio Grattagliano et al. BIOCHEMICAL PHARMACOLOGY
- Fibroblast Growth Factor 21—Metabolic Role in Mice and Men
- (2017) Harald Staiger et al. ENDOCRINE REVIEWS
- Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals
- (2017) Bo Kobberø Lauridsen et al. EUROPEAN HEART JOURNAL
- Pioglitazone inhibits mitochondrial pyruvate metabolism and glucose production in hepatocytes
- (2017) Christopher E. Shannon et al. FEBS Journal
- Nitro-oleic Acid Protects Mice from Diet-Induced Hepatic Steatosis and Insulin Resistance without the Adverse Side Effects of Thiazolidinediones
- (2017) Marco Fazzari et al. FREE RADICAL BIOLOGY AND MEDICINE
- Redox imbalance due to the loss of mitochondrial NAD(P)-transhydrogenase markedly aggravates high fat diet-induced fatty liver disease in mice
- (2017) Claudia D.C. Navarro et al. FREE RADICAL BIOLOGY AND MEDICINE
- The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
- (2017) Rohit Loomba et al. HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis
- (2017) Cyrielle Caussy et al. JOURNAL OF CLINICAL INVESTIGATION
- Effects of canagliflozin, an SGLT2 inhibitor, on hepatic function in Japanese patients with type 2 diabetes mellitus: pooled and subgroup analyses of clinical trials
- (2017) Yuya Seko et al. JOURNAL OF GASTROENTEROLOGY
- Treatment of NAFLD with diet, physical activity and exercise
- (2017) Manuel Romero-Gómez et al. JOURNAL OF HEPATOLOGY
- Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates
- (2017) Pi-Xiao Wang et al. NATURE MEDICINE
- The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis
- (2017) Peng Zhang et al. NATURE MEDICINE
- Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance
- (2017) Ruth C. R. Meex et al. Nature Reviews Endocrinology
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Non-alcoholic Fatty Liver Disease in Morbidly Obese Individuals Undergoing Bariatric Surgery: Prevalence and Effect of the Pre-Bariatric Very Low Calorie Diet
- (2017) Katherine J. P. Schwenger et al. OBESITY SURGERY
- Persistence of the mitochondrial permeability transition in the absence of subunit c of human ATP synthase
- (2017) Jiuya He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Permeability transition in human mitochondria persists in the absence of peripheral stalk subunits of ATP synthase
- (2017) Jiuya He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies
- (2017) Nishanth E. Sunny et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Beneficial effects of the Mediterranean spices and aromas on non-alcoholic fatty liver disease
- (2017) Laura Baselga-Escudero et al. TRENDS IN FOOD SCIENCE & TECHNOLOGY
- Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial
- (2017) Tisha R Joy et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Antioxidant dietary approach in treatment of fatty liver: New insights and updates
- (2017) Alessandra Ferramosca et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistance
- (2017) Joonseok Cho et al. Nature Communications
- Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2017) Giovanni Musso et al. JAMA Internal Medicine
- Mitotherapy for Fatty Liver by Intravenous Administration of Exogenous Mitochondria in Male Mice
- (2017) Ailing Fu et al. Frontiers in Pharmacology
- Pioglitazone Improves Mitochondrial Function in the Remnant Kidney and Protects against Renal Fibrosis in 5/6 Nephrectomized Rats
- (2017) Li Sun et al. Frontiers in Pharmacology
- Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats
- (2017) Shibin Ding et al. PLoS One
- BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis
- (2017) Adriana Carino et al. Scientific Reports
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
- (2016) Rohini Mehta et al. BMC Medical Genetics
- Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP
- (2016) Romeo Papazyan et al. Cell Metabolism
- Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
- (2016) Sahil Mittal et al. Clinical Gastroenterology and Hepatology
- An Intestinal Farnesoid X Receptor–Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice
- (2016) Cen Xie et al. DIABETES
- Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice
- (2016) Camella G. Wilson et al. ENDOCRINOLOGY
- Nonalcoholic Fatty Liver Disease
- (2016) Fernando Bril et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent
- (2016) Rosellina Margherita Mancina et al. GASTROENTEROLOGY
- In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores
- (2016) Jeffrey B. Schwimmer et al. GASTROENTEROLOGY
- Thyroid Hormone Receptor β Agonist Induces β-Catenin-Dependent Hepatocyte Proliferation in Mice: Implications in Hepatic Regeneration
- (2016) Tamara Feliciano Alvarado et al. GENE EXPRESSION
- Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
- (2016) Yaron Rotman et al. GUT
- Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
- (2016) Juan P. Arab et al. HEPATOLOGY
- Liraglutide ameliorates non-alcoholic fatty liver disease by enhancing mitochondrial architecture and promoting autophagy through the SIRT1/SIRT3-FOXO3a pathway
- (2016) Wenxin Tong et al. HEPATOLOGY RESEARCH
- Effect of liraglutide therapy on liver fat content in patients with inadequately controlled type 2 diabetes. The Lira-NAFLD study
- (2016) Jean-Michel Petit et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
- (2016) Jeffrey Cui et al. JOURNAL OF HEPATOLOGY
- Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment
- (2016) Meric Erikci Ertunc et al. JOURNAL OF LIPID RESEARCH
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
- (2016) Manoela Mota et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Resveratrol supplement inhibited the NF-κB inflammation pathway through activating AMPKα-SIRT1 pathway in mice with fatty liver
- (2016) Yueli Tian et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
- (2016) Barbara Gross et al. Nature Reviews Endocrinology
- Management of NAFLD: a stage-based approach
- (2016) Mary E. Rinella et al. Nature Reviews Gastroenterology & Hepatology
- The Role of Cholesterol in the Pathogenesis of NASH
- (2016) George N. Ioannou TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Silybin counteracts lipid excess and oxidative stress in cultured steatotic hepatic cells
- (2016) Giulia Vecchione et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Activation of necroptosis in human and experimental cholestasis
- (2016) Marta B Afonso et al. Cell Death & Disease
- Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling
- (2016) Pi-Xiao Wang et al. Nature Communications
- Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation
- (2016) Jia-Hung Ye et al. Scientific Reports
- Fibroblast Growth Factor Signaling in Metabolic Regulation
- (2016) Vera J. M. Nies et al. Frontiers in Endocrinology
- Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease
- (2015) Nishanth E. Sunny et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The mitochondrial-targeted antioxidant, MitoQ, increases liver mitochondrial cardiolipin content in obesogenic diet-fed rats
- (2015) Gilles Fouret et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling
- (2015) Kyle S. McCommis et al. Cell Metabolism
- Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism
- (2015) Ruth C. Meex et al. Cell Metabolism
- Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in Steatohepatitis
- (2015) Chrysi Koliaki et al. Cell Metabolism
- Physical exercise antagonizes clinical and anatomical features characterizing Lieber-DeCarli diet-induced obesity and related metabolic disorders
- (2015) Inês O. Gonçalves et al. CLINICAL NUTRITION
- Mechanisms of enterohepatic fibroblast growth factor 15/19 signaling in health and disease
- (2015) Daniel Jahn et al. CYTOKINE & GROWTH FACTOR REVIEWS
- TM6SF2: Catch-22 in the Fight Against Nonalcoholic Fatty Liver Disease and Cardiovascular Disease?
- (2015) Bratati Kahali et al. GASTROENTEROLOGY
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
- (2015) Guillaume Lassailly et al. GASTROENTEROLOGY
- Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysis
- (2015) Siddharth Singh et al. HEPATOLOGY
- Perilipin 5 improves hepatic lipotoxicity by inhibiting lipolysis
- (2015) Chao Wang et al. HEPATOLOGY
- Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice
- (2015) Karim Gariani et al. HEPATOLOGY
- Systematic literature review of determinants of sedentary behaviour in older adults: a DEDIPAC study
- (2015) Sebastien F M Chastin et al. International Journal of Behavioral Nutrition and Physical Activity
- Purified Anthocyanins from Bilberry and Black Currant Attenuate Hepatic Mitochondrial Dysfunction and Steatohepatitis in Mice with Methionine and Choline Deficiency
- (2015) Xilan Tang et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Letter to the Editor: The bioenergetics of hepatic mitochondria isolated from avocado oil-treated rats: typical experimental errors in the study of the bioenergetics of isolated mitochondria
- (2015) Dairo A. Rendon JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Protective effects of dietary avocado oil on impaired electron transport chain function and exacerbated oxidative stress in liver mitochondria from diabetic rats
- (2015) Omar Ortiz-Avila et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver
- (2015) Santhosh Satapati et al. JOURNAL OF CLINICAL INVESTIGATION
- Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
- (2015) Michaela Mueller et al. JOURNAL OF HEPATOLOGY
- Statin use and non-alcoholic steatohepatitis in at risk individuals
- (2015) Paola Dongiovanni et al. JOURNAL OF HEPATOLOGY
- Sab (Sh3bp5) dependence of JNK mediated inhibition of mitochondrial respiration in palmitic acid induced hepatocyte lipotoxicity
- (2015) Sanda Win et al. JOURNAL OF HEPATOLOGY
- Effect of aerobic exercise training dose on liver fat and visceral adiposity
- (2015) Shelley E. Keating et al. JOURNAL OF HEPATOLOGY
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
- (2015) Michal Pawlak et al. JOURNAL OF HEPATOLOGY
- Glucose fluctuation increased hepatocyte apoptosis under lipotoxicity and the involvement of mitochondrial permeability transition opening
- (2015) Xueyao Yin et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology
- (2015) Guy Bower et al. OBESITY SURGERY
- Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
- (2015) Hong-Mei Yan et al. PLoS One
- Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats
- (2015) R. J. Perry et al. SCIENCE
- Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander
- (2015) Ester Vanni et al. SEMINARS IN LIVER DISEASE
- Liraglutide, a Glucagon-Like Peptide-1 Analog, Increased Insulin Sensitivity Assessed by Hyperinsulinemic-Euglycemic Clamp Examination in Patients with Uncontrolled Type 2 Diabetes Mellitus
- (2015) Hideaki Jinnouchi et al. Journal of Diabetes Research
- Practice patterns in NAFLD and NASH: real life differs from published guidelines
- (2015) Mary E. Rinella et al. Therapeutic Advances in Gastroenterology
- Hepatokines as a Link between Obesity and Cardiovascular Diseases
- (2015) Hye Jin Yoo et al. Diabetes & Metabolism Journal
- 932 Pentoxifylline Improves Non-Invasive Serum Markers of Fibrosis: Combined Results From 2 Randomized, Placebo-Controlled Trials
- (2015) Claudia O. Zein et al. GASTROENTEROLOGY
- CerS2 Haploinsufficiency Inhibits β-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance
- (2014) Suryaprakash Raichur et al. Cell Metabolism
- Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
- (2014) Veronique S. Chachay et al. Clinical Gastroenterology and Hepatology
- The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
- (2014) Rifaat Safadi et al. Clinical Gastroenterology and Hepatology
- The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db/db mice without peroxisome proliferator-activated receptor gamma–associated adverse cardiac effects
- (2014) Rémy Hanf et al. Diabetes & Vascular Disease Research
- Oxysterols induce mitochondrial impairment and hepatocellular toxicity in non-alcoholic fatty liver disease
- (2014) Francesco Bellanti et al. FREE RADICAL BIOLOGY AND MEDICINE
- The mitochondrial-targeted antioxidant MitoQ ameliorates metabolic syndrome features in obesogenic diet-fed rats better than Apocynin or Allopurinol
- (2014) Christine Feillet-Coudray et al. FREE RADICAL RESEARCH
- No Significant Effects of Ethyl-Eicosapentanoic Acid on Histologic Features of Nonalcoholic Steatohepatitis in a Phase 2 Trial
- (2014) Arun J. Sanyal et al. GASTROENTEROLOGY
- Role of Mitochondria in Nonalcoholic Fatty Liver Disease
- (2014) Fatiha Nassir et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
- (2014) Changtao Jiang et al. JOURNAL OF CLINICAL INVESTIGATION
- The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis
- (2014) Fernando J. Barreyro et al. LIVER INTERNATIONAL
- The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
- (2014) Rachel J. Perry et al. NATURE
- Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
- (2014) Dmitry B. Zorov et al. PHYSIOLOGICAL REVIEWS
- Dynamic carbon 13 breath tests for the study of liver function and gastric emptying
- (2014) L. Bonfrate et al. Gastroenterology Report
- Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994
- (2013) Mariana Lazo et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Involvement of the mitochondrial permeability transition pore in chronic ethanol-mediated liver injury in mice
- (2013) Adrienne L. King et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Pleiotropic Roles of Bile Acids in Metabolism
- (2013) Thomas Q. de Aguiar Vallim et al. Cell Metabolism
- Peroxisome proliferator-activated receptor δ
- (2013) Lazar A. Bojic et al. CURRENT OPINION IN LIPIDOLOGY
- Dual Peroxisome Proliferator-Activated Receptor / Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
- (2013) B. Cariou et al. DIABETES CARE
- The effects of dietary restriction on oxidative stress in rodents
- (2013) Michael E. Walsh et al. FREE RADICAL BIOLOGY AND MEDICINE
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
- (2013) Jennifer E. Lambert et al. GASTROENTEROLOGY
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Interferon regulatory factor 3 constrains IKKβ/NF-κB signaling to alleviate hepatic steatosis and insulin resistance
- (2013) Xin-An Wang et al. HEPATOLOGY
- Berberine reverts hepatic mitochondrial dysfunction in high-fat fed rats: A possible role for SirT3 activation
- (2013) João Soeiro Teodoro et al. MITOCHONDRION
- Modulation of hepatic redox status and mitochondrial metabolism by exercise: Therapeutic strategy for liver diseases
- (2013) António Ascensão et al. MITOCHONDRION
- The global NAFLD epidemic
- (2013) Rohit Loomba et al. Nature Reviews Gastroenterology & Hepatology
- The biophysics and cell biology of lipid droplets
- (2013) Abdou Rachid Thiam et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Identification of a Mitochondrial Target of Thiazolidinedione Insulin Sensitizers (mTOT)—Relationship to Newly Identified Mitochondrial Pyruvate Carrier Proteins
- (2013) Jerry R. Colca et al. PLoS One
- PNPLA3-Associated Steatohepatitis: Toward a Gene-Based Classification of Fatty Liver Disease
- (2013) Marcin Krawczyk et al. SEMINARS IN LIVER DISEASE
- A silybin-phospholipids complex counteracts rat fatty liver degeneration and mitochondrial oxidative changes
- (2013) Ignazio Grattagliano WORLD JOURNAL OF GASTROENTEROLOGY
- Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program
- (2012) M. J. Armstrong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Mechanisms for Insulin Resistance: Common Threads and Missing Links
- (2012) Varman T. Samuel et al. CELL
- The Role of Endoplasmic Reticulum in Hepatic Lipid Homeostasis and Stress Signaling
- (2012) Suneng Fu et al. Cell Metabolism
- Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease
- (2012) Hae-Ki Min et al. Cell Metabolism
- Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
- (2012) G. Musso et al. DIABETOLOGIA
- Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial
- (2012) Carmela Loguercio et al. FREE RADICAL BIOLOGY AND MEDICINE
- Pioglitazone and vitamin E for nonalcoholic steatohepatitis: A cost utility analysis
- (2012) Suzanne E. Mahady et al. HEPATOLOGY
- Glycogen synthase kinase 3-mediated voltage-dependent anion channel phosphorylation controls outer mitochondrial membrane permeability during lipid accumulation
- (2012) Cecile Martel et al. HEPATOLOGY
- Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2012) Shelley E. Keating et al. JOURNAL OF HEPATOLOGY
- Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
- (2012) Geoffrey Porez et al. JOURNAL OF LIPID RESEARCH
- Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR
- (2012) Anna C. Calkin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Role of ceramides in nonalcoholic fatty liver disease
- (2012) Mangesh Pagadala et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease
- (2011) R. Dohil et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
- (2011) G. Vernon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Skeletal muscle and beyond: the role of exercise as a mediator of systemic mitochondrial biogenesis
- (2011) Jonathan P. Little et al. Applied Physiology Nutrition and Metabolism
- Nonalcoholic fatty liver disease
- (2011) Marcin Krawczyk et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Fatty acid transport proteins, implications in physiology and disease
- (2011) Melissa Kazantzis et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Excessive Hepatic Mitochondrial TCA Cycle and Gluconeogenesis in Humans with Nonalcoholic Fatty Liver Disease
- (2011) Nishanth E. Sunny et al. Cell Metabolism
- Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
- (2011) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- Liver ATP Synthesis Is Lower and Relates to Insulin Sensitivity in Patients With Type 2 Diabetes
- (2011) A. I. Schmid et al. DIABETES CARE
- The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/–/ApoE–/– mice
- (2011) John R. Mercer et al. FREE RADICAL BIOLOGY AND MEDICINE
- Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
- (2011) Claudia O. Zein et al. HEPATOLOGY
- Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2011) Helen M. Parker et al. JOURNAL OF HEPATOLOGY
- Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review
- (2011) Christian Thoma et al. JOURNAL OF HEPATOLOGY
- Improvement of Nonalcoholic Fatty Liver Disease After Bariatric Surgery in Morbidly Obese Chinese Patients
- (2011) Chi-Ming Tai et al. OBESITY SURGERY
- Oxidation of Hepatic Carnitine Palmitoyl Transferase-I (CPT-I) Impairs Fatty Acid Beta-Oxidation in Rats Fed a Methionine-Choline Deficient Diet
- (2011) Gaetano Serviddio et al. PLoS One
- Caloric restriction and redox state: Does this diet increase or decrease oxidant production?
- (2011) Alicia J Kowaltowski REDOX REPORT
- Human Fatty Liver Disease: Old Questions and New Insights
- (2011) J. C. Cohen et al. SCIENCE
- Expanding roles for lipid droplets
- (2011) Andrew S. Greenberg et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications
- (2011) Naim Alkhouri et al. Expert Review of Gastroenterology & Hepatology
- Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis
- (2010) M. O. Rakoski et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- 13C-octanoic acid breath test (OBT) with a new test meal (EXPIROGer®): Toward standardization for testing gastric emptying of solids
- (2010) Francesco Perri et al. DIGESTIVE AND LIVER DISEASE
- 13C-breath tests for clinical investigation of liver mitochondrial function
- (2010) Ignazio Grattagliano et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
- (2010) Christopher D. Williams et al. GASTROENTEROLOGY
- A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
- (2010) Giovanni Musso et al. HEPATOLOGY
- Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study
- (2010) Francesco Sofi et al. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
- Antioxidant Activities and Xanthine Oxidase Inhibitory Effects of Extracts and Main Polyphenolic Compounds Obtained fromGeranium sibiricumL.
- (2010) Nan Wu et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis
- (2010) Yuko Akazawa et al. JOURNAL OF HEPATOLOGY
- Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver
- (2010) Karima Begriche et al. JOURNAL OF HEPATOLOGY
- The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients
- (2010) Edward J. Gane et al. LIVER INTERNATIONAL
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oxidative Stress-Mediated Mitochondrial Dysfunction Contributes to Angiotensin II-Induced Nonalcoholic Fatty Liver Disease in Transgenic Ren2 Rats
- (2009) Yongzhong Wei et al. AMERICAN JOURNAL OF PATHOLOGY
- Pyruvate kinase in pig liver mitochondria
- (2009) Roberto Pizzuto et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Genistein and daidzein prevent low potassium-dependent apoptosis of cerebellar granule cells
- (2009) Anna Atlante et al. BIOCHEMICAL PHARMACOLOGY
- Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein
- (2009) Ling He et al. CELL
- Cytochrome c/cardiolipin relations in mitochondria: a kiss of death
- (2009) Valerian E. Kagan et al. FREE RADICAL BIOLOGY AND MEDICINE
- Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease
- (2009) Philippe Mathurin et al. GASTROENTEROLOGY
- Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
- (2009) Luca Miele et al. HEPATOLOGY
- Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
- (2009) Kittichai Promrat et al. HEPATOLOGY
- Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
- (2009) Vlad Ratziu et al. HEPATOLOGY
- Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease
- (2009) Zheng Zheng Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells
- (2009) Marco Trappoliere et al. JOURNAL OF HEPATOLOGY
- Adoption of PERILIPIN as a unifying nomenclature for the mammalian PAT-family of intracellular lipid storage droplet proteins: TABLE 1.
- (2009) Alan R. Kimmel et al. JOURNAL OF LIPID RESEARCH
- Endurance exercise causes mitochondrial and oxidative stress in rat liver: Effects of a combination of mitochondrial targeting nutrients
- (2009) Lijuan Sun et al. LIFE SCIENCES
- Lipolysis and lipid mobilization in human adipose tissue
- (2009) Max Lafontan et al. PROGRESS IN LIPID RESEARCH
- Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase
- (2008) Jing SHANG et al. ACTA PHARMACOLOGICA SINICA
- Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent
- (2008) Laura H. Tetri et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats
- (2008) R. Scott Rector et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance
- (2008) Justin I. Odegaard et al. Cell Metabolism
- Mitochondria andl-lactate metabolism
- (2008) Salvatore Passarella et al. FEBS LETTERS
- Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
- (2008) Vlad Ratziu et al. GASTROENTEROLOGY
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- Kinetic Analysis of Permeation of Mitochondria-Targeted Antioxidants Across Bilayer Lipid Membranes
- (2008) Tatyana I. Rokitskaya et al. JOURNAL OF MEMBRANE BIOLOGY
- Cessation of daily exercise dramatically alters precursors of hepatic steatosis in Otsuka Long-Evans Tokushima Fatty (OLETF) rats
- (2008) R. Scott Rector et al. JOURNAL OF PHYSIOLOGY-LONDON
- Liver Function as Assessed by Breath Tests in Patients With Hepatocellular Carcinoma
- (2008) Vincenzo O. Palmieri et al. JOURNAL OF SURGICAL RESEARCH
- Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia
- (2008) Hideyuki Hyogo et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease
- (2008) Mattias Ekstedt et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Nonalcoholic fatty liver disease and mitochondrial dysfunction
- (2008) Yongzhong Wei et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started